Global TradFi & Macroeconomics

Focus on price action and volatility across stocks, bonds, forex, commodities, and major indices. Analyze macro indicators like interest rates, inflation, employment, and policy expectations to decode global liquidity shifts, risk sentiment, and cross-market correlations.
All
Stocks
Metals
Indices
Forex
Commodities

CFETS-NEX CNY Funding Sentiment Index Falls to 54 on August 24

According to Jin10 Futures, on August 24 at 14:30, CFETS-NEX CNY funding sentiment index reported 54, down 1 point from 10:15. Large banks, mid-sized banks, and non-bank institutions reported sentiment readings of 53, 56, and 52 respectively, each declining 1 point. The index ranges from 0 to 100, w
GateNews·08-24 06:37
CFETS-NEX CNY Funding Sentiment Index Falls to 54 on August 24

Shein Targets $27 Billion Hong Kong IPO Valuation

Shein is planning a Hong Kong IPO to raise up to $1.77 billion by selling around 280 million class B shares priced between HK$47.60 and HK$49.50 per share, according to a filing on Monday. The offering values the fast fashion retailer at close to $27 billion at the top of that range. The company
GateMacroTradfiHub·08-24 06:35
Shein Targets $27 Billion Hong Kong IPO Valuation

Korean Stocks See Rising Short Positions Despite Price Surges

Short-selling positions increased in several Korean stocks that experienced recent price surges, as of the 19th, according to Korea Exchange data. The positions expanded despite upward price momentum, reflecting divergent investor expectations about these stocks' future direction. The phenomenon
GateMacroTradfiHub·08-24 06:29
Korean Stocks See Rising Short Positions Despite Price Surges

Bank of Korea Potential Growth Rate Revision Could Push Interest Rates Higher

The Bank of Korea is conducting potential growth rate estimation work that could create opposing forces on monetary policy, according to an August 24 report. If the potential growth rate rebounds from its declining trend, the resulting GDP gap reduction could exert downward pressure on medium- and s
GateMacroTradfiHub·08-24 06:25
Bank of Korea Potential Growth Rate Revision Could Push Interest Rates Higher

Moderna and Merck Announce Phase 3 Success for mRNA Cancer Vaccine

Moderna (NAS:MRNA) and Merck (NYS:MRK) announced the success of their Phase 3 clinical trial for a personalized mRNA cancer vaccine on 23일(현지시간), as reported by The Washington Post (WP). Mark Owick, a 73-year-old tennis coach from California, completed the 1-year trial after facing high recurrence r
MRNA+5.46%
MRK-0.11%
GateMacroTradfiHub·08-24 06:24
Moderna and Merck Announce Phase 3 Success for mRNA Cancer Vaccine